
Ece Cali Daylan, MD, PhD
@ececalidaylan
Thoracic oncologist 🫁 @wustl @sitemancenter via @montefioreNYC @einsteinmed
ID: 1487472904031899650
https://scholar.google.com/citations?user=TYMqrVEAAAAJ&hl=en&oi=ao 29-01-2022 17:09:48
79 Tweet
331 Followers
578 Following


🫁Lung cancer doesn’t discriminate ‼️ Narjust Florez, MD, FASCO It is affecting younger patients, do not ignore them! Powerful talk by the Lancet Commission #FlorezLab #ASCO24


Ladies who lung together #ASCO24 #lcsm IASLC ASCO Hem-Onc Fellows Network Hematology & Oncology Women Physicians Group—HOWPG


Hem/onc-there’s no core curriculum. The entire experience is an elective Outstanding class Montefiore Health System Albert Einstein College of Medicine - Official has chosen this elective as life mission-wish you’ll best of luck with half staying in Monte circles/others moving on to great things as far as Wash U/Jefferson!

Congratulations to the three researchers recognized by the Montefiore Staff & Alumni Association! They received the Henry L. Moses Awards in recognition of their exceptional clinical papers and contributions to healthcare. #MonteProud Albert Einstein College of Medicine - Official



Summary of our paper scim.ag/7p1 on combining JAK inhibitors with anti-PD1 for lung cancer (NSCLC). Part of a bench-to-bedside journey to understand opposing roles of IFN in IO. Wonderful team w E. John Wherry Divij Caitlin Foley Melina Marmarelis Joshua Bauml, MD et al! 1/13



#JCO welcomes our onboarding editorial fellows, Ayse Ece Cali Daylan, Michael Hughes, Peter Li, Joseph Mathew & @lcshihmd!





Very nice discussion on relapsed #SCLC by Dr. Anjali Rohatgi at #WCLC24. ADCs showing promise and easier to deliver than a BiTE like tarlatamab. No clear biomarker but encouraging efficacy. But we need randomized data to provide clear perspective.


🌟And here with the efficacy and safety data of #NVL655, ALK-selective, TRK-sparing and brain-penetrant 4G ALK TKI, from ALKOVE-1, presented today #ESMO24 by Alexander Drilon MD ✅ ORR 38% in heavily pretreated pts overall (1-5 prior ALK TKIs) ✅ ORR 35% in pts post-lorlatinib (in which


Honored and excited to be scientific co-chair of #ESMO25 together with Toni Choueiri, MD With FabriceAndre as incoming ESMO - Eur. Oncology president on our side we will be giving it our all! See you in #Berlin 🙏 Rebecca Dent for a fantastic, practice-changing #ESMO24. We learn from the best ❗️❗️


#ESMO24 Lung mini-orals🔥 Randomised ph II trial of inhaled corticosteroids in stage III NSCLC treated with cCRT, to reduce radiation pneumonitis: - 292pts - 15% reduction in RP - no long-term steroid tox No need for ph III, could do tomorrow #ESMOAmbassadors #ESMO24 ESMO - Eur. Oncology



The #WCLC24 Photo Gallery caught some great pics of the incredibly knowledgable contestants on our Meet The Expert Quiz Show! Thanks again to Drs. Natasha Leighl, Ben Solomon Ece Cali Daylan, MD, PhD Giannis Mountzios JessicaJLinMD Zac and Brinda Gupta!


EGFR mutant akciğer kanseri hakkında hem güncel hem de çok keyifli bu sohbeti kaçırmayın Saadettin Kılıçkap #akciğerkanseri #EGFR #onkoloji

Announcing the first EVER Journal of Clinical Oncology Art of Oncology Narrative Medicine Contest! 🎉✍️🎗️🩺🎉 We're looking for essays that explore the human experience of cancer and reflect on the experience of trainees and early career hematologists/oncologists. Apply Now! ascopubs.org/jco/art-oncolo…